FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomoyuki Takayama

Research Profile

Disorders

Heart Failure

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Takayoshi Tsutamoto; Hiroshi Sakai; Atsuyuki Wada; Chitose Ishikawa; Keijin Ohno; Masanori Fujii; Takashi Yamamoto; Tomoyuki Takayama; Tomohiro Dohke; Minoru Horie
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Masanori Fujii; Atsuyuki Wada; Masato Ohnishi; Takayoshi Tsutamoto; Takehiro Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Tomohiro Dohke; Takahiro Isono; Yutaka Eguchi; Minoru Horie
Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure.
Tomoyuki Takayama; Atsuyuki Wada; Takayoshi Tsutamoto; Masato Ohnishi; Masanori Fujii; Takahiro Isono; Minoru Horie
Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomoyuki Takayama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Takayoshi Tsutamoto; Hiroshi Sakai; Atsuyuki Wada; Chitose Ishikawa; Keijin Ohno; Masanori Fujii; Takashi Yamamoto; Tomoyuki Takayama; Tomohiro Dohke; Minoru Horie
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Journal of the American College of Cardiology 2004;44(11):2252-3.
2004: Masanori Fujii; Atsuyuki Wada; Masato Ohnishi; Takayoshi Tsutamoto; Takehiro Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Tomohiro Dohke; Takahiro Isono; Yutaka Eguchi; Minoru Horie
Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure.
Journal of cardiovascular pharmacology 2004;44 Suppl 1():S346-9.
2004: Tomoyuki Takayama; Atsuyuki Wada; Takayoshi Tsutamoto; Masato Ohnishi; Masanori Fujii; Takahiro Isono; Minoru Horie
Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor.
Circulation journal : official journal of the Japanese Circulation Society 2004;68(11):1067-75.
2004: Takayoshi Tsutamoto; Atsuyuki Wada; Masato Ohnishi; Takashi Tsutsui; Chitose Ishii; Keijin Ohno; Masanori Fujii; Takehiro Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Tomohiro Dohke; Minoru Horie
Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy.
European journal of heart failure 2004;6(2):173-80.
2003: Takayoshi Tsutamoto; Atsuyuki Wada; Masaru Hayashi; Takashi Tsutsui; Keiko Maeda; Masato Ohnishi; Masanori Fujii; Tetsuya Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Chitose Ishii; Masahiko Kinoshita
Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction.
European heart journal 2003;24(4):346-55.
2003: Takayoshi Tsutamoto; Atsuyuki Wada; Keiko Maeda; Masaru Hayashi; Takashi Tsutsui; Masato Ohnishi; Masanori Fujii; Takehiro Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Chitose Ishii
Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
Journal of cardiovascular pharmacology 2003;41 Suppl 1():S19-22.
2002: Takashi Yamamoto; Atsuyuki Wada; Masato Ohnishi; Takayoshi Tsutamoto; Masanori Fujii; Takehiro Matsumoto; Tomoyuki Takayama; Xinwen Wang; Kiyoshi Kurokawa; Masahiko Kinoshita
Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Clinical science (London, England : 1979) 2002;103 Suppl 48():258S-262S.
2002: Masato Ohnishi; Atsuyuki Wada; Takayoshi Tsutamoto; Masanori Fujii; Takehiro Matsumoto; Takashi Yamamoto; Tomoyuki Takayama; Xinwen Wang; Masahiko Kinoshita
Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Clinical science (London, England : 1979) 2002;103 Suppl 48():241S-244S.